Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kissei Pharmaceutical CoTSE:4547 +0.13%79 Interest Coverage is 94.38 as of Mar. 2026, which is 65% below its 10-year median of 269.70. GuruFocus rates TSE:4547 with a GF Score™ of 79/100 and a GF Value™ of 円4,688.48 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 687 Drug Manufacturers companies, Kissei Pharmaceutical Co ranks worse than 145560.26% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Kissei Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was 円755 Mil. Kissei Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was 円-8 Mil.
Kissei Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 94.38.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Kissei Pharmaceutical Co's Interest Coverage or its related term are showing as below:
TSE:4547's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.7 * Ranked among companies with meaningful Interest Coverage only.
Kissei Pharmaceutical Co (TSE:4547) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Kissei Pharmaceutical Co Interest Coverage Related Terms
Kissei Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kissei Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Kissei Pharmaceutical Co's Interest Coverage falls into.
Kissei Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kissei Pharmaceutical Co (TSE:4547) has a Interest Coverage of 94.38 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Kissei Pharmaceutical Co and its competitors. This is 65% below median its historical median of 269.70. According to the industry distribution chart, Kissei Pharmaceutical Co ranks #999999 out of 687 companies in the Drug Manufacturers industry.
Is Kissei Pharmaceutical Co's Interest Coverage too high?
Kissei Pharmaceutical Co's current Interest Coverage of 94.38 is 65% below median its 10-year median of 269.70. The Drug Manufacturers industry median Interest Coverage is 12.70. Kissei Pharmaceutical Co's value of 94.38 is 643.1% above this industry median. Based on the distribution chart, Kissei Pharmaceutical Co ranks #999999 out of 687 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kissei Pharmaceutical Co ranks #999999 out of 687 companies for Interest Coverage. This places Kissei Pharmaceutical Co in the lower half of its industry. The industry median Interest Coverage is 12.70. Kissei Pharmaceutical Co's value of 94.38 is 643.1% above this benchmark. While the company's 10-year median is 269.70 vs. the industry median of 12.70, Kissei Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.70, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kissei Pharmaceutical Co's current Interest Coverage of 94.38 is 643.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Kissei Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kissei Pharmaceutical Co's current Interest Coverage is 94.38, which is 65% below median its own 10-year median of 269.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co (TSE:4547) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,688.48, compared to a current price of 円3,860.00 — trading 17.7% below its estimated fair value. The current Interest Coverage is 94.38, which is 65% below median its 10-year median of 269.70 and 643.1% above the Drug Manufacturers industry median of 12.70. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Kissei Pharmaceutical Co (TSE:4547), the current Interest Coverage is 94.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kissei Pharmaceutical Co (TSE:4547) Overvalued in 2026?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円3,860.00 is trading 17.7% below its estimated GF Value™ of 円4,688.48.
GuruFocus considers Kissei Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TSE:4547:
Interest Coverage: 94.38 (65% below median its 10-year median of 269.70)
GF Value™: 円4,688.48 vs. price of 円3,860.00 (17.7% below fair value)
Industry Position: 643.1% above the Drug Manufacturers median (#999999 of 687)
No single metric tells the full story. See the TSE:4547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score
Get the complete analysis for TSE:4547
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4547 has been successfully added to your 
